These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 16784413)

  • 21. [Therapeutic strategies used by neurologists and primary care physicians in the symptomatic treatment of migraine. Findings from Strategia-I and Strategia-II opinion studies].
    Mateos V; Galván J; Heras J
    Rev Neurol; 2006 Nov 1-15; 43(9):513-7. PubMed ID: 17072805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The migraine cycle: patient burden of migraine during and between migraine attacks.
    Brandes JL
    Headache; 2008 Mar; 48(3):430-41. PubMed ID: 18179565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of the acute migraine headache.
    Aukerman G; Knutson D; Miser WF;
    Am Fam Physician; 2002 Dec; 66(11):2123-30. PubMed ID: 12484694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Building a migraine toolkit for patients: successful management of migraine headache.
    Schreiber CP
    Postgrad Med; 2003 Nov; 114(5 Suppl Understanding):27-35. PubMed ID: 19667647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Migraine--diagnosis and treatment.
    Joubert J
    Aust Fam Physician; 2005 Aug; 34(8):627-32. PubMed ID: 16113698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cost of migraine and its treatment.
    Goldberg LD
    Am J Manag Care; 2005 Jun; 11(2 Suppl):S62-7. PubMed ID: 16095269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuromodulators for migraine prevention.
    Kaniecki R
    Headache; 2008 Apr; 48(4):586-600. PubMed ID: 18205800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence-based medicine in migraine prevention.
    Yoon MS; Savidou I; Diener HC; Limmroth V
    Expert Rev Neurother; 2005 May; 5(3):333-41. PubMed ID: 15938666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How to Apply the AHS Evidence Assessment of the Acute Treatment of Migraine in Adults to your Patient with Migraine.
    Pringsheim T; Davenport WJ; Marmura MJ; Schwedt TJ; Silberstein S
    Headache; 2016 Jul; 56(7):1194-200. PubMed ID: 27322907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral metoclopramide as an adjunct to analgesics for the outpatient treatment of acute migraine.
    Azzopardi TD; Brooks NA
    Ann Pharmacother; 2008 Mar; 42(3):397-402. PubMed ID: 18285561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nebivolol and metoprolol for treating migraine: an advance on beta-blocker treatment?
    Schellenberg R; Lichtenthal A; Wöhling H; Graf C; Brixius K
    Headache; 2008 Jan; 48(1):118-25. PubMed ID: 18184294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defining refractory migraine and refractory chronic migraine: proposed criteria from the Refractory Headache Special Interest Section of the American Headache Society.
    Schulman EA; Lake AE; Goadsby PJ; Peterlin BL; Siegel SE; Markley HG; Lipton RB
    Headache; 2008 Jun; 48(6):778-82. PubMed ID: 18484982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment guidelines for preventive treatment of migraine].
    Treatment Guideline Subcommittee of the Taiwan Headache Society
    Acta Neurol Taiwan; 2008 Jun; 17(2):132-48. PubMed ID: 18686655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Migraine drug therapy: dental implications.
    Jeske AH
    Tex Dent J; 2006 Feb; 123(2):190-7. PubMed ID: 16579506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of early intervention with almotriptan vs placebo on migraine-associated functional disability: results from the AEGIS Trial.
    Freitag F; Smith T; Mathew N; Rupnow M; Greenberg S; Mao L; Finlayson G; Wright P; Biondi D;
    Headache; 2008 Mar; 48(3):341-54. PubMed ID: 18302700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Removing barriers to appropriate migraine treatment: formulary limitations and triptan package size.
    Silberstein SD; Dodick D; Kesslick J
    Headache; 2005 Oct; 45(9):1250-4. PubMed ID: 16178957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Menstrually related migraine: breaking the cycle in your clinical practice.
    Silberstein SD; Goldberg J
    J Reprod Med; 2007 Oct; 52(10):888-95. PubMed ID: 17977161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Moving forward to improve migraine management in Canada.
    Becker WJ; Giammarco R; Wiebe V
    Can J Neurol Sci; 2007 Nov; 34(4):S20-6. PubMed ID: 18062467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.